News & Updates

Long COVID, sometimes referred to as post-acute sequelae of COVID-19, is still highly prevalent despite improved acute treatments, the emergence of newer variants, and wider vaccination coverage, says an expert at ECCMID 2023.

High-risk outpatients with early-onset COVID-19 who are treated with oral fluvoxamine plus inhaled budesonide have a reduced incidence of severe disease that warrants advanced care, reveals a study.

An emulation of a randomized target trial suggests that molnupiravir may reduce hospital admission or death in adults who have tested positive for COVID-19 during the predominance of Omicron who were at high risk of progression to severe disease.

In Singapore, diagnostic radiographers were able to cope with the high demands of the COVID-19 pandemic in terms of provision of information, supplies, and physical equipment, a survey shows. However, they were less prepared to manage human factors, such as mental health and staff morale.

In patients with idiopathic pulmonary fibrosis (IPF) aged >56 years, carrying the MUC5B minor allele translates to improved median transplant-free survival at 16 months, results of a retrospective study in Europe have shown.

The bivalent mRNA-1273.214 booster vaccine provides superior immunogenicity compared with the original COVID-19 mRNA-1273 vaccine in a phase III study, according to an expert who presented at ECCMID 2023.

Patients with severe COVID-19 requiring mechanical ventilation are 16 times more likely to develop ventricular tachycardia (V-tach) within 6 months following discharge compared with matched controls without severe infection in a Swedish case-control study presented at EHRA 2023.